Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80
Published May 4, 2022 · Recall initiated: April 12, 2022
Summary
FDA records drug Class I recall D-0845-2022, published May 4, 2022 and initiated April 12, 2022. Recalling firm: Mylan Pharmaceuticals Inc; Status: Terminated; Reported quantity: 89,665 vials; Lot: Lot #: BF21002800, Exp 8/2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing label on the vial
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc
- Distributor
- USA nationwide.
- Lot
- Lot #: BF21002800, Exp 8/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,September 9, 2026
- FDAPrasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan PharmaceuticalsSeptember 9, 2026
- FDAAcamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan PharmaceuticalsAugust 26, 2026
- FDAInsulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDCAugust 3, 2022
- FDANAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, RxMay 4, 2022
- FDAAlign Digestive De-Stress Capsules 21ct bottle packaged in paper carton 12 cartons per caseMay 4, 2022
Questions about this recall
Was Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80 recalled?
Yes. FDA published recall D-0845-2022 on May 4, 2022. Reported hazard: Labeling: Missing label on the vial
What should I do if I have this product?
Voluntary: Firm initiated · Press Release